| Description | Burimamide is an antagonist of histamine. It appears to block both H2 and H3 histamine receptors. |
| molecular weight | 212.32 |
| Molecular formula | C9H16N4S |
| CAS | 34970-69-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Allan G, Eakins KE, Kulkarni PS, Levi R. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide. Br J Pharmacol. 1980;71(1):157-64. PubMed PMID: 6781572; PubMed Central PMCID: PMC2044402. 2. Hough LB, Nalwalk JW, Leurs R, Menge WM, Timmerman H. Antinociceptive activity of derivatives of improgran and burimamide. Pharmacol Biochem Behav. 2000 Jan 1;65(1):61-6. PubMed PMID: 10638637. 3. Harris DW, Smy JR, Reed JD, Venables CW. The effects of burimamide and metiamide on basal gastric function in the cat. Br J Pharmacol. 1975 Feb;53(2):293-7. PubMed PMID: 238700; PubMed Central PMCID: PMC1666291. 4. Nowak JZ, Pilc A. The influence of mepyramine and burimamide on histamine induced catalepsy in the rat. Acta Physiol Pol. 1975 Sep-Oct;26(5):529-32. PubMed PMID: 1241504. |